BIO Teams With Zerhouni On Quest For "New Big Ideas" To Speed Development
Executive Summary
BIO CEO Jim Greenwood is looking for "new big ideas" that would enable the pharmaceutical industry "to accelerate the pace of progress from academic research and translational research into products.
You may also be interested in...
BIO Creating "Game-Changing" Legislative Proposal To Boost R&D
BIO's blueprint for an economic and regulatory environment that facilitates innovation in biotechnology and the industry's ability to bring products to market could be finished within a few months.
BIO Creating "Game-Changing" Legislative Proposal To Boost R&D
BIO's blueprint for an economic and regulatory environment that facilitates innovation in biotechnology and the industry's ability to bring products to market could be finished within a few months.
Next Up, Parkinson's: Coalition Against Major Diseases Moves To Link Neurodegenerative Ailments In Database
Following the creation of an Alzheimer's disease database, firms will submit control trial data help develop Parkinson's and Huntington's biomarkers as well.